Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort - 09/08/11
, Martin D. Jarvis, PhD a, Anna P. Pilbrow, PhD a, Katrina L. Ellis, BSc a, Chris. M. Frampton, PhD a, Lorraine Skelton, RN a, Tim G. Yandle, PhD a, Rob N. Doughty, MD b, Gillian A. Whalley, PhD b, Chris J. Ellis, BM b, Richard W. Troughton, MBChB, PhD a, A. Mark Richards, MD, DSc a, Vicky A. Cameron, PhD aRésumé |
Background |
Polymorphisms of the angiotensin-converting enzyme 2 (ACE2) gene, which is located on the X chromosome, have been associated with hypertension and left ventricular hypertrophy in previous studies. We tested the hypothesis that the rare allele of an ACE2 gene polymorphism was associated with risk factors for and adverse outcome after acute coronary syndrome (ACS) events.
Methods |
Patients (n = 1,042) were recruited after admission for an ACS event and were genotyped for the A1075G polymorphism of the angiotensin-converting enzyme 2 gene. This genetic marker was tested for association with baseline measurements, echocardiographic measurements, and clinical outcome, over a median 2.19 years follow-up. As the ACE2 gene is X-linked, analyses were performed separately for males and females. Patients were predominantly of European ethnicity (90.1%).
Results |
The A1075 allele was significantly associated with covariate-adjusted mortality in male patients (hazard ratio 1.95, 95% CI 1.10-3.46, P = .047) but not unadjusted (hazard ratio 1.14, 95% CI 0.736-1.76, P = .56). The G1075 (P < .035) allele was more frequent in patients of Maori compared to European ancestry. E/E′, an echocardiographic index of left ventricular diastolic function and filling pressure, was higher in males in the A1075 group (G allele group 10.5 [95% CI 10.0-11.0], A allele group 11.4 [95% CI 10.8-12.1], P = .024). A1075 genotype was significantly associated with male survival in the absence of (mortality: A 12.8%, n = 39; G 29.2%, n = 48; P = .037) but not in the presence of β-blocker treatment (mortality: A 13.5% n = 273; G 8.2% n = 304, P = nonsignificant).
Conclusions |
The A1075 allele was associated with covariate-adjusted mortality in male patients.
Le texte complet de cet article est disponible en PDF.Plan
| Funding from a University of Otago (Dunedin, New Zealand) ORG grant, the Health Research Council of NZ (Auckland, New Zealand), the National Heart Foundation (NHF) of NZ (Auckland, New Zealand), the Maurice and Phyllis Paykel Trust (Auckland, New Zealand), and Lottery Health (Wellington, New Zealand) is acknowledged. A.P.P. held a Foundation for Research and Technology Postdoctoral Fellowship, G.A.W. a NHF Senior Fellowship, and A.M.R. the NHF Chair of Cardiovascular Studies. |
Vol 156 - N° 4
P. 752-758 - octobre 2008 Retour au numéro
Article précédent
- Systemic exposure of everolimus after stent implantation: A pharmacokinetic study
- Marcus Wiemer, Ashok Seth, Praveen Chandra, Jörg Neuzner, Gert Richardt, Jan J. Piek, Martin Desaga, Carlos Macaya, Cornelis J. Bol, Karine Miquel-Hebert, Karolien De Roeck, Patrick W. Serruys
- Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men
- Rachel Lampert, J. Douglas Bremner, Shaoyong Su, Andrew Miller, Forrester Lee, Faiz Cheema, Jack Goldberg, Viola Vaccarino
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?